Cantor Fitzgerald Downgrades Flex Pharma (FLKS) to Hold
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Cantor Fitzgerald downgraded Flex Pharma (NASDAQ: FLKS) from Buy to Hold with a price target of $10.00 (from $22.00).
Shares of Flex Pharma closed at $8.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Time Warner (TWX) to Neutral Following Takeover
- Needham & Company Raises Price Target on II-VI, Inc. (IIVI) Ahead of 1Q Release
- SunTrust Downgrades Everyday Health (EVDY) to Hold
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Related EntitiesCantor Fitzgerald
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!